International operations grew 37.4% in Laxmi Dental's Q1FY27
The consolidated quarter carried a 19.23% operating margin, while the company added 3 support facilities in India.
Filed 11 Aug 2026, 19:21 IST · after market close · LAXMIDENTL (LAXMIDENTL)
Key takeaways
- International operations grew 37.4% year-on-year in Q1FY27, leading the dental laboratory business.
- Consolidated operating margin was 19.23%, with net profit at Rs 10.31 cr and EPS at Rs 1.87.
- Laxmi Dental established 3 new support facilities in India while focusing on AI-led automation and operating efficiencies.
International business led the Q1FY27 operating update
Laxmi Dental reported consolidated revenue of Rs 74.7 cr and operating profit of Rs 14.36 cr for Q1FY27, translating into a 19.23% operating margin. The company said its dental laboratory business grew 23.5% year-on-year, with international operations growing 37.4%. Its Aligner Solutions business grew 28.6%, led by Bizdent at 27.8% and Vedia at 29.3%.
Profit included Rs 3.07 cr of other income
Consolidated profit before tax was Rs 12.81 cr, while other income contributed Rs 3.07 cr. Interest expense was Rs 0.3 cr and depreciation was Rs 4.32 cr; the reported tax rate was 19.47%. Net profit was Rs 10.31 cr, or Rs 1.87 per share.
Three new Indian facilities support regional expansion
Management said the company established 3 support facilities across Indian cities to deepen regional presence, improve market penetration and provide better service to dental partners. It also said it is strengthening its on-ground leadership presence in the U.S. and focusing on AI-led automation and operating efficiencies. The results were filed after market close on 11 August 2026.
Q1FY27 at a glance
Consolidated figures as filed with NSE — filed ahead of third-party databases, not yet independently cross-checked.
| Line item | Q1FY27 |
|---|---|
| Revenue | ₹75 cr |
| Other income | ₹3 cr |
| Expenses | ₹60 cr |
| Operating profit | ₹14 cr |
| Operating margin (%) | 19.23% |
| Interest | ₹0 cr |
| Depreciation | ₹4 cr |
| Profit before tax | ₹13 cr |
| Tax | ₹2 cr |
| Net profit | ₹10 cr |
| EPS (₹) | ₹1.87 |
What management said
From the company’s own investor presentation. Each point is checked against the source document before it appears here.
This quarter
- Q1FY27 dental laboratory revenue grew 23.5% year-on-year, with international operations growing 37.4%.
- The Aligner Solutions business grew 28.6% year-on-year, with Bizdent and Vedia growing 27.8% and 29.3%.
Expansion
- The company established three new support facilities across multiple Indian cities to deepen regional presence and improve service.
New initiatives
- The company is strengthening its on-ground leadership presence in the U.S. to sharpen its market-focused strategy and sustain growth.
- The company is focusing on AI-led automation and improving operational efficiencies.
Competition
- The company describes itself as the second-largest domestic laboratory player and the largest export laboratory.
What to watch
- Whether operating margin holds above 19.23% in the next reported quarter.
- Whether international operations sustain growth from the reported 37.4% year-on-year rate.
- The contribution from the 3 new Indian support facilities to business growth and service coverage.